Company Overview
Tenet Healthcare Corporation functions as a diversified healthcare services entity operating primarily within the United States, delivering critical medical care through its Hospital Operations and Services segment alongside an Ambulatory Care segment. These operational segments provide acute care services, including operating and recovery rooms, radiology, and respiratory support, while also managing ambulatory facilities. The company operates within the broader Healthcare sector, specifically the Medical Care Facilities industry, positioning it as a significant provider of essential medical infrastructure and services. Currently, the enterprise holds a market capitalization of $18.03B and generates annual revenue of $21.31B, supported by a workforce of 77,000 employees. These valuation and revenue figures indicate that Tenet maintains a substantial presence in the market, reflecting a large-scale operation capable of influencing local healthcare dynamics while maintaining a significant asset base relative to its peers.
Financial Health
The company reports trailing twelve-month revenue of $21.31B, net income of $1.41B, and EBITDA of $4.63B, illustrating a robust top-line performance. The substantial gap between the $21.31B revenue and the $1.41B net income reveals a cost structure where approximately 93.4% of revenue is consumed by expenses before reaching the bottom line, highlighting the capital-intensive nature of hospital operations. Despite this, the firm generates free cash flow of $1.68B, which provides essential financial flexibility for debt servicing, capital expenditures, and potential strategic acquisitions without relying solely on external financing. Profitability is supported by a gross margin of 41.4%, an operating margin of 17.5%, and a profit margin of 6.6%, where the gross margin reflects efficient service delivery costs, the operating margin indicates effective internal management of overhead, and the profit margin demonstrates the final return to shareholders after all obligations. Regarding liquidity and leverage, the company holds $2.88B in cash against total debt of $14.43B, resulting in a debt-to-equity ratio of 160.79, which characterizes the balance sheet as highly leveraged rather than conservative. Short-term liquidity appears manageable with a current ratio of 1.76, suggesting the firm possesses sufficient current assets to cover its short-term liabilities. Furthermore, the Return on Equity stands at 27.0% while Return on Assets is 8.0%, metrics that collectively reveal management's effectiveness in generating shareholder value relative to equity investment and utilizing the total asset base efficiently.
Valuation Assessment
Valuation metrics indicate a trailing P/E ratio of 13.24 and a forward P/E of 11.68, where the difference between these figures implies that the market anticipates an acceleration in earnings growth in the coming periods relative to current performance. The price-to-book ratio is 4.23, indicating that the market values the company at a significant premium over its tangible book value, reflecting expectations of future growth or intangible asset worthiness. Alternative valuation measures include a price-to-sales ratio of 0.85 and an EV/EBITDA of 7.37, which suggest the stock is priced at a discount relative to sales compared to many growth sectors but remains reasonable when adjusted for enterprise value and earnings before interest, taxes, depreciation, and amortization. The 52-week trading range spans from a low of $109.82 to a high of $247.21, placing the current valuation context within this historical volatility band. The stock exhibits a beta of 1.41, meaning its price volatility is significantly higher than the broader market, moving 41% more aggressively than the S&P 500 in response to market fluctuations.
Growth & Income
Recent performance data shows revenue growth of 8.9% year-over-year and earnings growth of 27.6% year-over-year, demonstrating that earnings are expanding at a rate more than three times faster than revenue, which implies operational leverage and potential efficiency improvements or margin expansion. As a non-dividend payer, the company reports a dividend yield of N/A and a payout ratio of 0.0%, indicating that the firm does not distribute cash to shareholders but instead retains earnings to fund operations and growth initiatives. This retention strategy aligns with the company's reinvestment model, prioritizing capital allocation toward business expansion and infrastructure over dividend distributions. The overall growth and income profile is characterized by high earnings velocity and a zero-dividend policy, presenting a capital appreciation opportunity rather than an income generation vehicle for investors seeking current yield.